ACADIA PHARMACEUTICALS INC — Director's Dealing 2014

Nov 21, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACADIA PHARMACEUTICALS INC (ACAD)
CIK: 0001070494
Period of Report: 2014-11-21

Reporting Person: Wells William McDowall (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-11-21	Common Stock	M	5810	$1.36	Acquired	5810	Direct
2014-11-21	Common Stock	S	5810	$29	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-11-21	Stock Option (right to buy)	$1.36	M	5810	Disposed	2022-06-07	Common Stock (5810)	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in March 2014.

F2: 25% of the shares subject to the stock option vested and became exercisable at the end of each 3-month period following the date of grant of June 8, 2012.